Private Placement Litigation: When the Deal Goes Sideways

Private placements are supposed to be the quiet corner of the securities markets. Regulation D, Rule 506, accredited investors, sophisticated counterparties, negotiated terms, limited disclosure obligations relative to public offerings. The premise of the entire private capital ecosystem is that the parties to a Reg D transaction are capable of protecting their own interests and have agreed to a documentary framework that allocates risk between them.

When the deal goes well, that premise holds. When it does not, the litigation that follows is some of the most complex and consequential commercial litigation in the system. The investor who has lost a meaningful portion of a multi-million-dollar investment is not a passive plaintiff. The placement agent or broker-dealer who placed the offering is not a passive defendant. The sponsor whose business plan did not perform as projected is not insulated from claims simply because the offering documents were comprehensive. The litigation that follows tests every assumption built into the original transaction, and the lawyers who defend it are working in an area where decades of accumulated doctrine intersects with the contemporary mechanics of how private capital actually changes hands.

I have defended placement agents, broker-dealers, sponsors, and individual principals in private placement disputes across a range of industries — real estate, energy, technology, financial services, and the increasingly common operating businesses that raise growth capital through private channels. The patterns are consistent enough to be useful, but the strategic considerations require attention to detail that generalist defense counsel often miss.

The Threshold Question: What Was Sold, and to Whom?

Every private placement litigation begins with two threshold questions: what security was sold, and to whom was it sold? The answers to those questions determine the legal framework that governs every claim that follows.

The “what” question is more complex than it appears. The instrument at issue may be a limited partnership interest, an LLC membership interest, a preferred equity instrument, a convertible note, a SAFE, or a participation in a more complex structure. Each of these instruments comes with its own documentary framework, its own statutory characterization, and its own implications for the duties owed by the issuer, the placement agent, and any control persons. The defense theory must begin with a precise understanding of what the plaintiff actually purchased, because the duties that attach to that purchase will frame every claim and every defense.

The “to whom” question is equally important. The federal securities laws and most state blue sky laws distinguish between accredited investors and non-accredited investors, between sophisticated investors and unsophisticated investors, and between institutional purchasers and retail purchasers. The plaintiff who was an accredited investor at the time of purchase has access to a different set of claims than the plaintiff who was not. The plaintiff who was sophisticated in the relevant subject matter — real estate, energy, financial services — faces a higher reliance threshold than the plaintiff who was not. The defense team that does not develop the investor’s accreditation status, financial sophistication, and prior investment experience as a first-order matter is missing one of the most important strands of defensive doctrine available to it.

The Subscription Documents as Shield and Sword

The subscription documents in a private placement are typically drafted to protect the issuer and the placement agent. They contain investor representations about accreditation, sophistication, investment intent, and the receipt and review of offering materials. They contain acknowledgments about the speculative nature of the investment, the absence of a secondary market, the absence of governmental review of the offering documents, and the investor’s ability to bear the loss of the entire investment. They contain integration clauses, non-reliance clauses, and increasingly choice-of-law and forum-selection clauses that govern any subsequent dispute.

When the deal goes sideways, these provisions become central to the litigation. The investor’s representations are evidence that contradicts later claims of unsophistication or detrimental reliance on extraneous statements. The acknowledgments establish that the risks the investor now complains of were disclosed. The integration and non-reliance provisions limit the universe of statements on which the investor can claim to have relied.

But the subscription documents cut both ways. The investor’s lawyer will argue that the representations were boilerplate, that the acknowledgments were not specifically negotiated, and that the integration provisions cannot extinguish federal securities law claims. Each of these arguments has support in the case law, and each requires a defense response that is grounded in the specific facts of the offering rather than reliance on the documents alone. The defense lawyer who relies on the subscription documents as a complete defense is the defense lawyer who loses summary judgment when the court declines to read those documents as the parties intended.

Rule 10b-5 in the Private Placement Context

The federal securities law claim that drives most private placement litigation is Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder. The elements are familiar: material misrepresentation or omission, scienter, reliance, and loss causation. But the application of these elements in the private placement context differs from the application in public market litigation in ways that affect defense strategy meaningfully.

The fraud-on-the-market presumption that drives class certification in public securities litigation does not apply to private placements. The plaintiff in a private placement case must establish actual reliance — that the plaintiff actually read or heard the alleged misrepresentation, actually relied on it in making the investment decision, and would have made a different decision absent the misrepresentation. This is a fact-intensive inquiry that creates substantial defense opportunities at deposition, at summary judgment, and at trial.

The materiality analysis is similarly fact-intensive in the private placement context. The materiality of a representation in a private offering depends on the totality of the information available to the investor, including the offering memorandum, the financial projections, the side communications between the placement agent and the investor, and the investor’s independent diligence. A representation that would be plainly material in a public offering — where investors have only the public disclosure to rely on — may be considerably less material in a private placement where the investor had access to substantial additional information.

The scienter analysis in the private placement context often turns on what the sponsor and the placement agent knew and when they knew it. The defense team that has not built a contemporaneous record of the diligence performed before the offering, the basis for the projections included in the offering memorandum, and the communications between the placement agent and the investor is the defense team that will struggle to establish the absence of scienter when the investor argues that the deal team knew the business was failing before the offering closed.

State Law Claims and the Choice-of-Law Question

Federal securities law claims are not the only claims investors bring when private placements fail. State blue sky claims, common law fraud, negligent misrepresentation, breach of contract, breach of fiduciary duty, and unjust enrichment all appear regularly in these cases. Each of these claims has different elements, different burdens of proof, different statutes of limitations, and different damages frameworks.

The choice-of-law question therefore becomes strategically important. The offering documents typically contain choice-of-law provisions, but those provisions are not always enforceable, and the application of those provisions to non-contract claims is contested in most jurisdictions. The defense team that has not analyzed which state’s law will govern which claim — and the implications of that choice for the elements the plaintiff must prove — is missing strategic opportunities that often determine the outcome of these cases.

I have defended cases in which the choice-of-law analysis essentially decided the matter. A claim governed by one state’s law might require proof of reliance with clear and convincing evidence; the same claim governed by a different state’s law might require only a preponderance. A claim governed by one state’s law might be subject to a three-year statute of limitations from discovery; the same claim governed by a different state’s law might run from the date of the transaction. These differences are not technicalities. They are the substantive framework within which the case will be tried, and the defense team that controls the choice-of-law analysis often controls the outcome.

Placement Agent and Broker-Dealer Liability

The placement agent or broker-dealer that introduced the investor to the offering occupies a particularly exposed position in private placement litigation. The investor’s theory is typically that the placement agent owed duties — under Reg BI, under FINRA rules, under common law agency principles, or under the placement agreement itself — that were breached in the marketing of the offering or the suitability of the investment for the particular investor.

The defense of placement agents requires understanding that the duties owed by a placement agent in a Reg D offering differ from the duties owed by a broker-dealer in a discretionary account. The placement agent is generally not a fiduciary in the traditional sense. The placement agent is selling a specific product to investors who have represented their accreditation and sophistication. The agency relationship runs to the issuer, not to the investor, in most placement structures. These distinctions matter enormously when the investor seeks to characterize the placement agent’s role in ways that imply broader duties than the placement structure actually involved.

That said, the defense cannot rely on the placement agent’s limited formal duties alone. The actual conduct of the placement — the communications between the placement agent and the investor, the representations made about the offering and the sponsor, the suitability analysis performed before the placement — will be examined in detail by the plaintiff’s lawyer and by the fact-finder. The defense that has the strongest record on these issues is the defense that prevails. The defense that relies on the formal allocation of duties without addressing the actual conduct of the placement is the defense that loses.

The Diligence Question

One of the recurring themes in private placement litigation is the adequacy of the diligence performed before the offering. The investor’s theory will often be that the placement agent or the sponsor did not perform sufficient diligence on the business, the projections, or the underlying assets, and that more careful diligence would have surfaced the issues that ultimately caused the investment to fail.

The defense response requires demonstrating not just that diligence was performed but that the diligence performed was reasonable given the nature of the offering, the size of the placement, the sophistication of the investors, and the customary practices of the relevant market. This is fundamentally an expert-driven inquiry. The placement agent’s diligence practices will be evaluated by an expert in placement agent practices. The sponsor’s underwriting will be evaluated by an industry expert. The financial projections will be evaluated by a valuation or industry expert.

The defense team that selects, prepares, and presents these experts effectively wins the diligence battle. The defense team that treats diligence as a fact issue rather than as an expert issue is fighting on terrain where the plaintiff’s narrative is naturally more compelling than the defense’s. Diligence is technical. It is industry-specific. It requires expert testimony to establish what reasonable practice looked like at the relevant time, and it requires expert testimony to defend the practices actually followed.

The Settlement Dynamics

Most private placement disputes settle before trial, and the settlement dynamics in these cases reward defense teams that have prepared the matter for trial. The plaintiff who believes the defense has not built a serious record settles for more. The plaintiff who has been deposed thoroughly, whose expert has been challenged on Daubert grounds, and whose theory has been tested at summary judgment settles for less.

I have negotiated settlements in private placement cases at the courthouse door and I have negotiated them eighteen months into discovery. The difference between favorable and unfavorable settlement outcomes is almost always the quality of the trial preparation that preceded the settlement. The defense team that approaches a private placement case as a trial matter from the first day will produce settlement leverage that the defense team treating the matter as a paper case never develops.

The premise of the Reg D regime is that sophisticated parties can allocate risk between themselves through negotiated documents and informed investment decisions. That premise is sound, but the litigation that follows when deals fail does not respect the premise. It examines every assumption, every representation, and every communication that bears on the investor’s loss. The defense team that prepares for that examination as the rigorous, fact-intensive exercise it is — rather than as a documentary defense built on subscription representations alone — is the defense team that protects its clients when the deal goes sideways.

—

Otto K. Hilbert, II is a Trial Attorney with AEGIS Law. He brings over 36 years of first-chair trial and appellate experience to representing clients in complex commercial litigation, securities defense, and regulatory enforcement matters. He has tried cases in 23 states and is admitted before the United States Supreme Court and multiple United States Courts of Appeals.

This article is provided for general informational purposes and does not constitute legal advice. Readers facing specific legal matters should consult qualified counsel.